Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Brigitte Nelken Meinolf Suttorp |
| Publication date | February 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |